Videos

RSS icon
Subhasis Chatterjee, MD, FACS, FACC, FCCP, Associate Professor of Surgery, Director Thoracic Surgical ICU and ECMO Program, Baylor St. Lukes, explains the new 2026 guidelines for management of new onset post-operative atrial fibrillation (AFib), which he spoke about at the American Association for Thoracic Surgery (AATS) 2026 annual meeting.

New STS guideline tackles the prevention of AFib after cardiac surgery

Among the guideline's most significant changes is a Class I recommendation for prophylactic amiodarone.

Ahmad M. Slim, MD, FACC, FASNC, FSCCT, chair of the SCCT Health Policy and Practice Committee, Chief Medical Officer at Pulse Heart Institute, and associate professor of medicine, University of Washington, delivered a state of the union for coronary CT angiography (CCTA) policy, changes in payment models, advocacy effort, and payer engagement during the Society of Cardiovascular Computed Tomography (SCCT) 2026 annual meeting. #SCCT #SCCT2026 #YesCCT #CCTA

SCCT highlights payment gains, policy challenges as coronary CT use surges

An increase of nearly 200% in the use of CCTA over the past year has driven policy changes.

Yader Sandoval, MD, FACC, FSCAI, an interventional cardiologist at the Minneapolis Heart Institute, and an adjunct associate professor of medicine at Mayo Clinic, explains how coronary computed tomography angiography (CCTA) is being used increasingly to pre-plan percutaneous coronary interventions (PCI).

CCTA being used more and more to plan ahead before complex PCI

Interventional cardiologist Yader Sandoval, MD, discusses the growing trend of using CCTA imaging to plan ahead before complex PCI procedures.

Coronary CT angiography (CCTA) is emerging as a powerful tool not only for diagnosing coronary artery disease, but also for tracking how patients respond to preventive therapies over time, according to Mark G. Rabbat, MD, FACC, FAHA, FSCCT, professor of medicine and radiology and director of cardiac imaging at Loyola University Medical Center.

CCTA highlights plaque regression due to treatment

CCTA can show the regression of atherosclerosis due to drug therapies over time, so it may be a good tool to identify those patients who need of more aggressive therapy.

ynthia McCollough, PhD, FAAPM, FACR, FAIMBE, professor of medical physics and biomedical engineering, and director of the CT Clinical Innovation Center and X-ray imaging core at Mayo Clinic, Rochester, has been working on conventional CT and photon-counting CT research for years. She shares and overview of the advantages of photon-counting CT scanners as compared to conventional EID (energy-integrating detector) technology.

Photon-counting CT vs. conventional detector technologies

Computed tomography research medical physicist Cynthia McCollough, PhD, Mayo Clinic, explains the advantages of photon-counting CT systems.

Matthew Budoff, MD, FACC, FAHA, FSCCT, a professor of medicine at David Geffen School of Medicine at UCLA and the Endowed Chair of Preventive Cardiology at Harbor-UCLA Medical Center, and former SCCT president, explains how new CCTA technologies will change cardiac preventive care.

AI-powered CCTA plaque analysis advances personalized preventive cardiology

Matthew Budoff, MD, explains how AI-powered plaque analysis and FFR-CT are transforming cardiac preventive care.
 

Suhny Abbara, MD, FACR, MSCCT, FNASCI, senior associate consultant and professor of radiology, Mayo Clinic, Jacksonville, Florida, and editor of the RSNA journal Radiology, gave high praises to opportunistic AI screenings for coronary calcium at SCCT 2026. He said there are more than 20 million chest CTs performed each year in the U.S., which holds a massive promise to detect millions of new patients with asymptomatic coronary artery disease that the patient is unaware of. #SCCT #YesCCT #Radiology

Opportunistic chest CT screening could identify undiagnosed heart disease in many patients

The greatest opportunity is detecting coronary atherosclerosis in younger patients undergoing CT for unrelated reasons, including trauma evaluations.

Imre Hunyor, DPhil (Oxon), MBBS (Hons), explained Central Sydney Cardiology’s clinical implementation of Christo's CaRi-Heart fat attenuation index (FAI) imaging technology. It is the first clinical implementation in Australia. The technology uses artificial intelligence (AI) to review coronary CT angiography (CCTA) scans for inflammation in the fat surrounding the arteries. This can add additional, specific information on a patient's risk for heart attacks otherwise is not detectable using current tech.

AI-based coronary inflammation imaging detects risk that may have otherwise been missed

FAI CCTA imaging uses AI to show coronary inflammation and a patient's specific residual risk of heart attack that is not available using current testing methods.

Displaying 33 - 40 of 751
Design by Adaptive Theme